Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity study of hepatitis B antigen in the GSK candidate malaria vaccine
PACTR201104000284208Unknown
- Sponsor
- GSK
- Start
- Apr 2011
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Trial of Hepatitis B vaccine in malaria and hepatitis B (HBV) (5 arms), sponsored by GSK. Primary endpoint: Non-inferiority of hepatitis B immune response. Status: unknown.
02
Drugs
Hepatitis B vaccine
03
Conditions
malariahepatitis B (HBV)
Beyond the preview
Go deeper on PACTR201104000284208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201104000284208.